ArticleCancers2026

A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial.

Maria Cristina Pirosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.